UNIVERSITY OF MICHIGAN
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1817-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.umich.edu
UVA1 Light for Treatment of Scleroderma and Similar Conditions
Not Applicable
Completed
- Conditions
- Other Fibrosing ConditionsSclerodermaKeloids
- Interventions
- Device: German manufactured UVA1 light emitting device
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2015-07-10
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 27
- Registration Number
- NCT00476801
- Locations
- 🇺🇸
University of Michigan Department of Dermatology, Ann Arbor, Michigan, United States
UVA1 Light for Scleroderma and Similar Conditions
Not Applicable
Terminated
- Conditions
- Granuloma AnnulareAcne Keloidalis NuchaeKeloidSclerodermaScars
- Interventions
- Device: German manufactured UVA1 emitting light system
- First Posted Date
- 2007-05-22
- Last Posted Date
- 2015-07-27
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 23
- Registration Number
- NCT00476697
- Locations
- 🇺🇸
University of Michigan Department of Dermatology, Ann Arbor, Michigan, United States
Healthy Eating for Colon Cancer Prevention
Not Applicable
Completed
- Conditions
- Colon Cancer
- Interventions
- Behavioral: 1 Healthy EatingBehavioral: 2 Mediterranean
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 120
- Registration Number
- NCT00475722
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
The Fruit and Vegetable Study
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: written materials onlyBehavioral: written materialsBehavioral: telephone support
- First Posted Date
- 2007-05-02
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 97
- Registration Number
- NCT00468156
- Locations
- 🇺🇸
Ypsilanti Family Health Center, Ypsilanti, Michigan, United States
Lay Theories of Health in Young and Middle Aged American Adults
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-04-09
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 302
- Registration Number
- NCT00458172
The Effect Of A Controlled Daily Skin Care Regimen On Retinoic Acid Tolerance
Not Applicable
Completed
- Conditions
- Retinoid IntoleranceSun-Damaged Skin
- Interventions
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 40
- Registration Number
- NCT00440024
- Locations
- 🇺🇸
University of Michigan Department of Dermatology, Ann Arbor, Michigan, United States
Web-based Education to Enhance Fibromyalgia Management
Not Applicable
Completed
- Conditions
- FibrositisFibromyalgia
- Interventions
- Behavioral: Standard care and webBehavioral: Standard Care
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2011-10-10
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 118
- Registration Number
- NCT00423631
- Locations
- 🇺🇸
Avera Research Institute, Sioux Falls, South Dakota, United States
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
Not Applicable
Completed
- Conditions
- Hypertriglyceridemia With the Metabolic Syndrome
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 60
- Registration Number
- NCT00422396
- Locations
- 🇺🇸
Northwestern University preventive Cardiology Center, Chicago, Illinois, United States
Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study
Completed
- Conditions
- Chronic Kidney DiseaseAnemia
- First Posted Date
- 2006-11-06
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 12
- Registration Number
- NCT00396123
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis
Phase 4
Completed
- Conditions
- Chronic Rhinosinusitis
- Interventions
- Drug: probiotic containing L.rhamnosus R0011 strainOther: Placebo
- First Posted Date
- 2006-11-06
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 77
- Registration Number
- NCT00396162
© Copyright 2025. All Rights Reserved by MedPath